PMCPA Case
| Case numbers | AUTH/2915/12/16; AUTH/2916/12/16 |
| Parties | Anonymous (non-contactable) v Janssen-Cilag Ltd and Napp Pharmaceuticals Limited |
| Product | Invokana (canagliflozin) |
| Issue | Appropriateness of venue and subsistence for a promotional meeting; partner logo on invitation |
| Meeting | “A Practical Guide to Manage Type 2 Diabetes and its Complications” (December 2016) |
| Timing | 18:30 registration & buffet; education from ~19:30; close 21:30 |
| Subsistence cost | £48.88 per health professional attendee (food and drinks) |
| Panel view | Venue and cost were on the limits of acceptability, but did not amount to a breach |
| Clauses considered | 2; 9.1; 22.1 |
| Outcome | No breach (both cases) |
| Complaint received | 12 December 2016 |
| Case completed | 20 January 2017 |
| Appeal | No appeal |
| Applicable Code year | 2016 |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.